MonetizationLicensingSelling patents

Patent monetization: the routes available

By Ipiry TeamPublished August 26, 20267 min read

Short answer

Six routes exist: practise it yourself, sell it, license it, enforce it, hold it defensively, or release it deliberately. Only selling ends the maintenance fee obligation while paying you. Licensing generates income but leaves every ongoing cost and risk with you. Enforcement is expensive and puts the patent itself at risk. Most patents suit none of these, which is why 58.6% are abandoned before term.

Patent monetization has six routes, and two of them happen by default if you do nothing.

Practise, sell, license, enforce, hold defensively, or release.

Only one both ends the cost and pays you. Selling. Licensing generates income and leaves every ongoing obligation where it was.

And most patents suit none of the six, which is why 58.6% of US utility patents are abandoned before term.

The six routes

Route	Ends the fees?	Pays you?	Cost to pursue
Practise it	No	Via the product	Commercial
Sell	Yes	Yes, once	Low — broker commission
License	No	Yes, ongoing	Moderate — monitoring
Enforce	No	Possibly, large	Very high
Hold defensively	No	No	The fees
Release	Yes	No	None

Two happen by default. Paying the fee, and letting it lapse. Neither requires a decision, and both are frequently what happens when nobody makes one.

Practising it

Feature	Detail
Value source	The product, not the patent
Patent's role	Keeps competitors out
Fees	Still yours
Marking	Required to start damages without a notice letter
Most common route	For operating companies

The patent is a moat, not a revenue line. Its value shows up as margin protected rather than income received.

Mark your products. Failure to mark limits damages to the date of actual notice, which can eliminate years of recovery. See patent marking.

Selling

Feature	Detail
Mechanism	Assignment — permanent transfer
What ends	Fees, enforcement, validity defence, administration
Payment	Single, certain
Timeline	Months
Requires	Clean chain of title, in-force status, remaining term
Value driver	Evidence claims read on shipping products

A sale ends every row of the ongoing cost table at once. That is worth real money on a patent you would otherwise carry for another decade.

Start early. Twelve months before a fee deadline keeps the full process available. See how to sell my patent.

Licensing

Feature	Detail
Ownership	Stays with you
Maintenance fees	Stay with you
Enforcement against non-licensees	Yours
Validity defence	Yours
Monitoring and audits	Yours
Revenue	Ongoing, uncertain
Types	Non-exclusive, sole, exclusive; field and territory limits

Field-of-use limits turn one patent into several assets. A patent licensed exclusively for one application remains licensable for others.

Run the arithmetic against the fees. A $30,000 annual royalty against an approaching $8,280 fee plus monitoring is thinner than it looks. See types of IP licences.

Enforcement

Reality	Detail
Cost	Frequently millions per side
Time to trial	Years
Validity risk	The patent can be lost entirely
Parallel PTAB proceeding	Adds cost and risk
Damages floor	Reasonable royalty
Most cases	Settle
Fee awards	Available to defendants too

Asserting a patent puts it at risk. An IPR filed in response can end the asset, not just the claim.

A notice letter has two effects. It starts the knowledge clock supporting willfulness, and it gives the recipient standing to sue first in a forum they choose.

Marking avoids that trade-off, starting the damages period without inviting a filing. See patent infringement damages.

Defensive holding

Value	Depends on
Something to assert if sued	Coverage of what the opponent does
Deterrence	Credibility of assertion
Cross-licensing currency	Portfolio relevance
Not on patent count	Coverage, not volume

Defensive value is specific, not general. A hundred patents covering nothing your likely opponents do provide no leverage at all.

Identify who the opponent would be and check whether your claims reach them. If not, the defensive rationale is not doing the work it is credited with.

Deliberate release

	Deliberate	By inattention
Decision made	Yes	No
Sale considered first	Yes	No
Timing	Chosen	Forced
Value captured	Possibly	None

Releasing a patent is a legitimate outcome. The market does it constantly, because the fees escalate while the remaining term shrinks.

The failure is not releasing — it is releasing without having considered selling.

What the market actually does

Ipiry Patent Survival Curve v1.0	Rate
Survive the 3.5-year fee (2022 cohort)	85.8%
Survive the 7.5-year fee (2018 cohort)	64.6%
Reach full term (2014 cohort)	41.4%
Abandoned before full term	58.6%
Lost at the first fee	14.2%
Lost at the second fee	21.2 points
Lost at the third fee	23.2 points
Conditional: paid first two, pay third	63.0%

Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.

The conditional figure is the useful benchmark. Of patents already paid for twice — assets their owners believed in enough to fund through two windows — 37% are still released at the third.

The costs any route must clear

Fee	Due after grant	Large	Small	Micro
First	3.5 years	$2,150	$860	$430
Second	7.5 years	$4,040	$1,616	$808
Third	11.5 years	$8,280	$3,312	$1,656
Total		$14,470	$5,788	$2,894

Foreign annuities add more, annually, per country. A four-country family can cost several times the US total across its life.

Worked example: one patent, four routes priced

Eight years of term remaining, small entity, claims reading on two competitor products.

Route	Gross	Costs	Net position
Do nothing, pay fees	$0	$4,928 remaining fees	−$4,928
License non-exclusively	$25,000/yr × 8	Fees + monitoring + audits	Positive, admin-heavy
Sell	Single payment	Broker commission only	Certain, ends everything
Enforce	Potentially large	Millions, years, validity risk	High variance
Lapse at the next window	$0	$0	−0, value forgone

What decided it

Factor	Effect
Documented claim chart on both products	Made the sale possible
Eight years remaining	Enough for a buyer
Clean recorded chain	No blocker
No budget for enforcement	Ruled that route out
Owner does not practise	Ruled out route one

The claim chart was the enabling asset, not the patent alone. A patent with documented evidence of use is a different thing from one without. See claim chart example.

Enforcement was ruled out by budget, not by merit. That is the ordinary case for individual owners and small companies.

What makes any route work

Requirement	Why
Claims read on real products	The largest single factor
Documented evidence of that	Turns belief into an asset
In force	58.6% are not
Clean recorded ownership	Gaps stop transactions
Meaningful remaining term	Under 3 years is very hard
No unresolved encumbrances	Liens, exclusive licences

Verify the first four yourself before pursuing anything. All are free and take under an hour. See patent status.

Timing decides more than route choice

Start	Options available
12+ months before a fee deadline	All six
6 months	Sale compressed, licensing viable
3 months	Difficult
6 weeks	Pay or lapse
After the grace period	None

Run a portfolio review annually against eighteen months of deadlines, and phrase each entry as a decision rather than a payment. See patent portfolio management.

Patent monetization: the checklist

Know all six routes. Two of them happen by default.
Only selling ends the fees and pays you. Licensing does neither of the first.
Check whether anyone practises the claims. That decides everything downstream.
Build a claim chart before approaching anyone. It is the value driver.
Price licensing against the remaining fees, not against zero.
Treat enforcement as putting the patent at risk, not just the claim.
Mark products rather than sending letters where possible.
Test defensive rationales against who the opponent would actually be.
Release deliberately if nothing else fits — but consider selling first.
Start twelve months before a deadline. Timing removes options faster than anything else.

Common questions

What are the ways to monetize a patent?

Practising the invention commercially, selling the patent outright, licensing it, enforcing it against infringers, holding it defensively, or deliberately releasing it. Each has different cost, risk and return characteristics.

Which route pays the most?

It depends entirely on the asset. Practising a patented invention in a successful product usually generates the most value. Among the others, a sale gives certainty now while licensing gives a larger but uncertain total over time.

Does selling end my costs?

Yes. Assignment transfers ownership permanently, so maintenance fees, enforcement responsibility, validity defence and administration all move to the buyer. Licensing ends none of them, which is the main structural difference between the two.

Is enforcement worth it?

Only where damages would substantially exceed cost and the patent is robust. Litigation runs into millions per side, takes years, and puts the patent at risk, since an asserted patent is a challenged patent.

What is defensive value?

Holding patents that give you something to assert if someone sues you, which changes the economics of an assertion against you. The value depends on covering what a potential opponent does, not on how many patents you hold.

Can a patent with no infringers be monetized?

Rarely. Evidence that claims read on products in the market is the largest single factor in what a buyer pays, and licensing requires someone who needs the licence. Without either, deliberate release is often the rational outcome.

When should I sell rather than license?

When you want certainty over total, when the administrative burden outweighs the income, or when you cannot fund enforcement. Selling converts an uncertain stream and an ongoing cost into a single payment.

How long does a patent sale take?

Months rather than weeks, covering buyer identification, diligence and negotiation. Starting twelve months before a maintenance fee deadline keeps the full process available; six weeks generally does not.

What makes a patent monetizable?

Claims that read on products people actually sell, documented evidence of that, verified in-force status, clean recorded ownership, and meaningful remaining term. Failing any one of those makes every route harder.

Should I send a demand letter?

Carefully. A notice letter starts the knowledge clock supporting later willfulness claims, and it also gives the recipient standing to file a declaratory judgment action in a forum of their choosing.

Is deliberately lapsing a patent a failure?

No. Releasing an asset that no longer earns its escalating fees is a rational decision, and the market makes it constantly. The failure is lapsing by inattention when the patent could have been sold first.

What is the most common mistake?

Waiting until a fee deadline forces the decision. A patent sold before the deadline is worth something and the same patent afterwards is worth nothing, and selling takes months.

How to sell my patent

The steps to sell a patent, what buyers ask for at diligence, how the assignment works, what brokers charge, and why the maintenance fee deadline is the deadline that matters.

Patent royalty rates: what they are and how they are set

Typical patent royalty rates by industry, the base the rate applies to, how the 25% rule and Georgia-Pacific factors work, and why the base matters more than the percentage.

Patent portfolio management: the operating cadence

How to run a patent portfolio operationally — the review cycle, the four-way decision at each fee window, how to rank patents cheaply, and what a defensible budget looks like.

What is your patent worth?

Free AI valuation in 60 seconds, benchmarked against 652,000 KPSS patent value records and the Ipiry Patent Survival Curve.

Value My Patent Free →Takes 60 seconds. No credit card required.